Amplia Therapeutics Limited

ATX

Amplia Therapeutics Ltd. is a medical biotechnology company, which engages in the development of drugs for potential use in multiple indications including oncology and chronic fibrosis. The company is headquartered in Melbourne, Victoria. The company went IPO on 2013-12-23. The firm is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The firm's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The firm's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.

Atrum Coal Limited

ATU

Atrum Coal Ltd. explores and develops coal properties. The company is headquartered in Sydney, New South Wales. The company went IPO on 2012-07-24. The firm is engaged in Elan Hard Coking Coal Project, which is located in the Crowsnest Pass area of southern Alberta, Canada. The company operates through two segments: Exploration and All other segments. The Exploration segment consists of mineral exploration and development in Canada. The firm's projects include the Elan Hard Coking Coal Project and the Groundhog and Panorama Anthracite Projects. The Elan Hard Coking Coal Project which is located in the Crowsnest Pass area of southern Alberta, Canada. The Groundhog and Panorama Anthracite Projects are located in northern British Columbia, Canada. The Groundhog Project offers several large potential development areas suitable for multiple joint venture and/or partnership development opportunities. The Panorama North Project hosts a 174 Mt inferred resource.

Activeport Group Ltd

ATV

ActivePort Group Ltd. develops software. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-10-20. Its segments include ActivePort Software, Managed Service Provider (MSP), Network and Corporate services. Its assets are its network orchestration software, its network-as-service platform, and its information systems managed services business. The ActivePort software business offers software to customers that use it to orchestrate their networks and connect their customers to the cloud. The network as a service (NaaS) platform called Global Edge enables organizations to connect their operations to the cloud using a self-service Web interface. The managed services business delivers mission-critical information technology, services and support to enterprise customers across Australia and parts of Southeast Asia. The company helps its customers provide on-demand services, network device configuration and connections to cloud providers.